中国武汉COVID-19肺炎患者院内心脏骤停结局
该回顾性研究按Utstein模式收集2020年1月15日至2月25日武汉某三级教学医院所有院内心脏骤停心肺复苏尝试的数据,共136例重症COVID-19肺炎患者。87.5%的心脏骤停为呼吸性原因,83.1%在普通病房复苏,初始心律以无脉性电活动以外的心律停搏为主(89.7%)。自主循环恢复18例(13.2%),30天生存4例(2.9%),30天神经功能预后良好1例。作者结论为武汉重症COVID-19肺炎患者院内心脏骤停生存率差。
要点
- 136例重症COVID-19肺炎院内心脏骤停患者中,自主循环恢复18例(13.2%),30天生存仅4例(2.9%)。
- 初始心律为停搏者占89.7%,无脉性电活动占4.4%,可电击心律占5.9%。
- 119例(87.5%)心脏骤停为呼吸性原因,113例(83.1%)在普通病房接受复苏。
- 93.4%的患者接受监测,89%的复苏在1分钟内启动。
- 心脏骤停地点和初始心律与较好结局相关。
适用人群与场景
- 2020年1月15日至2月25日武汉某三级教学医院发生院内心脏骤停并接受心肺复苏的重症COVID-19肺炎患者,共136例。
研究设计与关键结果
- 回顾性研究,136例重症COVID-19肺炎院内心脏骤停患者,按Utstein模式收集数据;主要终点自主循环恢复18例(13.2%),次要终点30天生存4例(2.9%)、30天神经功能预后良好1例。
- 119例(87.5%)心脏骤停为呼吸性原因,113例(83.1%)在普通病房复苏;初始心律停搏89.7%、无脉性电活动4.4%、可电击心律5.9%。
- 93.4%的患者接受监测,89%的复苏在1分钟内启动;平均住院时间7天,从发病至入院时间10天。
- 最常见合并症为高血压(30.2%),最常见症状为气短(75%);心脏骤停地点和初始心律与较好结局相关。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论为武汉重症COVID-19肺炎患者院内心脏骤停生存率差。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To describe the characteristics and outcomes of patients with severe COVID-19 and in-hospital cardiac arrest (IHCA) in Wuhan, China.
METHODS: The outcomes of patients with severe COVID-19 pneumonia after IHCA over a 40-day period were retrospectively evaluated. Between January 15 and February 25, 2020, data for all cardiopulmonary resuscitation (CPR) attempts for IHCA that occurred in a tertiary teaching hospital in Wuhan, China were collected according to the Utstein style. The primary outcome was restoration of spontaneous circulation (ROSC), and the secondary outcomes were 30-day survival, and neurological outcome.
RESULTS: Data from 136 patients showed 119 (87.5%) patients had a respiratory cause for their cardiac arrest, and 113 (83.1%) were resuscitated in a general ward. The initial rhythm was asystole in 89.7%, pulseless electrical activity (PEA) in 4.4%, and shockable in 5.9%. Most patients with IHCA were monitored (93.4%) and in most resuscitation (89%) was initiated <1 min. The average length of hospital stay was 7 days and the time from illness onset to hospital admission was 10 days. The most frequent comorbidity was hypertension (30.2%), and the most frequent symptom was shortness of breath (75%). Of the patients receiving CPR, ROSC was achieved in 18 (13.2%) patients, 4 (2.9%) patients survived for at least 30 days, and one patient achieved a favourable neurological outcome at 30 days. Cardiac arrest location and initial rhythm were associated with better outcomes.
CONCLUSION: Survival of patients with severe COVID-19 pneumonia who had an in-hospital cardiac arrest was poor in Wuhan.
参考来源
- Shao F, Xu S, Ma X, et al. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation. 2020. PMID: 32283117. doi:10.1016/j.resuscitation.2020.04.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。